RESUMEN
Use of shared electronic health records opens a whole range of new possibilities for flexible and fruitful cooperation among health personnel in different health institutions, to the benefit of the patients. There are, however, unsolved legal and security challenges. The overall aim of this article is to highlight legal and security challenges that should be considered before using shared electronic cooperation platforms and health record systems to avoid legal and security "surprises" subsequent to the implementation. Practical lessons learned from the use of a web-based ulcer record system involving patients, community nurses, GPs, and hospital nurses and doctors in specialist health care are used to illustrate challenges we faced. Discussion of possible legal and security challenges is critical for successful implementation of shared electronic collaboration systems. Key challenges include (1) allocation of responsibility, (2) documentation routines, (3) and integrated or federated access control. We discuss and suggest how challenges of legal and security aspects can be handled. This discussion may be useful for both current and future users, as well as policy makers.
Asunto(s)
Acceso a la Información/legislación & jurisprudencia , Seguridad Computacional/legislación & jurisprudencia , Confidencialidad/legislación & jurisprudencia , Registros Electrónicos de Salud/legislación & jurisprudencia , Política de Salud , Difusión de la Información/legislación & jurisprudencia , Telemedicina/legislación & jurisprudencia , Humanos , Noruega , Grupo de Atención al Paciente , Formulación de Políticas , Úlcera/diagnóstico , Úlcera/terapiaRESUMEN
OBJECTIVE: This work investigates the relationship between early body composition changes and neurodevelopment at 1 year age corrected for prematurity (CA). STUDY DESIGN: A prospective, longitudinal study to measure body composition weekly in 34 very low birth weight preterm infants using air displacement plethysmography, beginning when infants stabilized after birth until discharge. Neurodevelopmental testing (Bayley Scales of Infant Development-III) was performed at 12 months CA. Linear mixed effects models were used to obtain inpatient subject-specific changes in fat-free mass (FFM) and fat mass (FM), which were then used as predictors of Bayley subscale scores in subsequent linear regression models, adjusting for potential confounders. Protein and energy provision were calculated for the first week of life. RESULTS: Greater FFM gains while inpatient were associated with improved cognitive and motor scores at 12 months CA (P = .002 for both). These relationships remained significant when adjusting for birth weight, gestational age, and intraventricular hemorrhage (P ≤ .05 for both). Similar analysis was performed for FM gains without significant findings. Increased provision of protein and calories during the first week of life was positively associated with FFM gains (P ≤ .01 for both), but not FM gains (P ≥ .2 for both), throughout hospitalization. CONCLUSIONS: Increased FFM gains, but not FM gains, during hospitalization are associated with improved neurodevelopment at 12 months CA. As early FM gains may be associated with long-term risk, more research is needed to develop strategies that optimize FFM gains while minimizing FM gains in very low birth weight preterm infants.
Asunto(s)
Composición Corporal , Cognición , Recien Nacido Prematuro/crecimiento & desarrollo , Recién Nacido de muy Bajo Peso , Desempeño Psicomotor , Femenino , Humanos , Lactante , Recién Nacido , Modelos Lineales , Estudios Longitudinales , Masculino , Pletismografía de Impedancia , Estudios ProspectivosRESUMEN
PROBLEM: In some Federally-Qualified Community Health Centers (FQHCs), patients do not have a designated primary care provider (PCP). Patients see any provider who is available. This leads to fragmented care, poorer outcomes, and higher costs. DESIGN: Patients were empaneled to a designated PCP. Continuity, quality, and efficiency measures were collected at baseline, 6-, and 12-months postempanelment. BACKGROUND AND SETTING: Three rural FQHCs on the coast of Northern California performing about 18,000 patient visits annually. KEY MEASURES FOR IMPROVEMENT: Patient cycle time, percentage of patient visits with designated PCPs, completion of cervical and colorectal cancer screenings; blood pressure, low-density lipoprotein, and hemoglobin A1c control in patients with diabetes. STRATEGIES FOR CHANGE: The senior Leadership Team initiated the patient empanelment project with the assistance of an outside consultant. EFFECTS OF CHANGE: After 12 months, 100% of the FQHC's patients were assigned a PCP and saw that provider on ≥63% of visits. Quality indicators improved by an average of 9% and cycle time decreased by 12 min. per patient allowing providers to see approximately four more patients and generate an additional $2212 per day. LESSONS LEARNT: Project outcomes supported the importance of a designated PCP to achieve improved quality and efficiency of care.
Asunto(s)
Continuidad de la Atención al Paciente/tendencias , Atención Primaria de Salud/métodos , Mejoramiento de la Calidad/tendencias , California , Reforma de la Atención de Salud/métodos , Humanos , Atención Primaria de Salud/normas , Atención Primaria de Salud/tendenciasRESUMEN
BACKGROUND: Transfer for primary percutaneous coronary intervention (PCI) is superior to fibrinolysis if performed in a timely manner but frequently requires dislocation of patients and their families from their local community. Although patient satisfaction is increasingly viewed as an important quality indicator, there are no data on how emergent transfer for PCI affects patients with ST-segment-elevation myocardial infarction and their families. METHODS AND RESULTS: The Minneapolis Heart Institute's Level 1 Regional ST-Segment-Elevation Myocardial Infarction program is designed to facilitate emergent transfer for PCI in patients with ST-segment-elevation myocardial infarction from 31 rural and community hospitals. To determine the effect of emergent transfer, questionnaires were given to 152 patients and their families who survived to hospital discharge with a 65.8% response rate (mean age, 63.9 years; 29% women). Ninety-five percent of patients felt the reasons and process of transfer were well explained, and 97% felt transfer for care was necessary. Despite this, 15% of patients would have preferred to stay in their local hospital. The majority of the families felt the transfer process (88%) and family member's condition (94%) were well explained. Although 99% felt it was necessary for their family member to be transferred for specialized care, 11% of families still would have preferred that their family members remain at the local community hospital. CONCLUSIONS: Our results suggest that ST-segment-elevation myocardial infarction patients and families can be informed, even in time-critical situations, about the transfer process for PCI and understand the need for specialized care. Still, a significant minority would prefer to stay at their local hospital, despite acknowledging transfer for PCI provided optimal care.
Asunto(s)
Infarto del Miocardio/epidemiología , Infarto del Miocardio/terapia , Satisfacción del Paciente/estadística & datos numéricos , Transferencia de Pacientes/estadística & datos numéricos , Intervención Coronaria Percutánea , Anciano , Cuidadores , Electrocardiografía , Servicios Médicos de Urgencia , Femenino , Hospitales Rurales , Humanos , Masculino , Persona de Mediana Edad , Minnesota , Prioridad del PacienteRESUMEN
Functional outcomes of elderly patients ≥80 years who undergo percutaneous coronary intervention (PCI) for ST elevation myocardial infarction (STEMI) are unknown. Registry data indicate that up to 55% of elderly patients with STEMI do not receive reperfusion therapy despite a suggested mortality benefit, and only limited data are available regarding outcomes in elderly patients treated with primary PCI. Therefore, prospective data from a regional STEMI transfer program were analyzed to determine major adverse cardiac events, length of stay, and discharge status of consecutive patients with STEMI ≥80 years from March 2003 to November 2006. Of the 1,323 consecutive patients with STEMI treated in this regional STEMI system from March 2003 to November 2006, 199 (15.0%) were ≥80 years old. In-hospital mortality in elderly patients was 11.6%, with a 1-year mortality rate of 25.6%. Of the 166 patients with age ≥80 who lived independently or in assisted living before hospital admission and survived, 150 (90.4%) were discharged to a similar living situation or projected to such a living situation after temporary nursing home care. The median length of hospital stay was 4 days for these patients. In conclusion, elderly patients with age ≥80 receiving PCI for STEMI in a regional STEMI program have short hospital stays and excellent functional recovery on the basis of a very high rate of return to a similar previous living situation.
Asunto(s)
Actividades Cotidianas/clasificación , Actividades Cotidianas/psicología , Angioplastia Coronaria con Balón , Infarto del Miocardio/terapia , Calidad de Vida/psicología , Stents , Factores de Edad , Anciano , Anciano de 80 o más Años , Angioplastia Coronaria con Balón/mortalidad , Angioplastia Coronaria con Balón/psicología , Anticoagulantes/administración & dosificación , Bloqueo de Rama/mortalidad , Bloqueo de Rama/psicología , Bloqueo de Rama/terapia , Causas de Muerte , Femenino , Mortalidad Hospitalaria , Humanos , Estimación de Kaplan-Meier , Tiempo de Internación/estadística & datos numéricos , Masculino , Minnesota , Infarto del Miocardio/mortalidad , Infarto del Miocardio/psicología , Transferencia de Pacientes , Estudios Prospectivos , Terapia TrombolíticaRESUMEN
BACKGROUND: Although hematopoietic stem cell transplantation (HSCT) is the treatment of choice for childhood myelodysplastic syndrome (MDS), there is no consensus regarding patient or disease characteristics that predict outcomes. PROCEDURE: We reviewed 37 consecutive pediatric MDS patients who received myeloablative HSCT between 1990 and 2010 at a single center. RESULTS: Twenty had primary MDS and 17 had secondary MDS. Diagnostic cytogenetics included monosomy 7 (n = 21), trisomy 8 (n = 7) or normal/other (n = 8). According to the modified WHO MDS classification, thirty had refractory cytopenia and seven had refractory anemia with excess blasts. IPSS scores were: low risk (n = 1), intermediate-1 (n = 15), and intermediate-2 (n = 21). OS and DFS at 10 years in the entire cohort was 53% and 45%. Relapse at 10 years was 26% and 1 year TRM was 25%. In multivariate analysis, factors associated with improved 3 years DFS were not receiving pre-HSCT chemotherapy (RR = 0.30, 95% CI 0.10-0.88; P = 0.03) and a shorter interval (<140 days) from time of diagnosis to transplant (RR = 0.27, 95% CI 0.09-0.80; P = 0.02). Three years DFS in patients who did not receive pre-HSCT chemotherapy and those who had a shorter interval to transplant (n = 16) was 80%. CONCLUSION: These results suggest that children with MDS should be referred for allogeneic HSCT soon after diagnosis and that pre-HSCT chemotherapy does not appear to improve outcomes.
Asunto(s)
Trasplante de Células Madre Hematopoyéticas , Síndromes Mielodisplásicos/mortalidad , Síndromes Mielodisplásicos/cirugía , Adolescente , Antineoplásicos/uso terapéutico , Niño , Preescolar , Supervivencia sin Enfermedad , Femenino , Humanos , Lactante , Estimación de Kaplan-Meier , Masculino , Síndromes Mielodisplásicos/tratamiento farmacológico , Recurrencia Local de Neoplasia/epidemiología , Estudios Retrospectivos , Resultado del Tratamiento , Adulto JovenRESUMEN
The oral bioaccessibility of soil contaminants is increasingly assessed with physiologically based extraction tests (PBETs): the contaminant fraction that is desorbed into simulated digestive fluids is measured and classified as bioaccessible. However, this approach can lead to underestimations if the capacity of the fluids is insufficient to provide infinite sink conditions. Desorption will then progressively decrease and finally stop when equilibrium between soil and medium is reached. To circumvent this artifact, we incorporated a silicone rod as an absorption sink into the PBET to continuously absorb mobilized contaminants and maintain the desorption gradient. Polycyclic aromatic hydrocarbons served as model contaminants and the colon extended PBET as the extraction model. The inclusion of the silicone rod sink (1) increased the extraction capacity of the test by orders of magnitude, (2) ensured near infinite sink conditions, and (3) allowed for simple back-extraction of PAHs for their quantification by GC-MS. The silicone rod provided fast enrichment when applied to the stomach and small intestine compartment, but was somewhat slower in the richer colon compartment. Finally, the sorptive-PBET was applied to wood soot and a kindergarten soil. The present article provides the basis for how an absorption sink can be integrated into PBET models.
Asunto(s)
Monitoreo del Ambiente/métodos , Hidrocarburos Policíclicos Aromáticos/aislamiento & purificación , Siliconas/química , Contaminantes del Suelo/aislamiento & purificación , Absorción , Ingestión de Alimentos , Cromatografía de Gases y Espectrometría de Masas , Mucosa Gástrica/metabolismo , Humanos , Intestino Delgado/metabolismo , Hidrocarburos Policíclicos Aromáticos/metabolismo , Suelo/análisis , Contaminantes del Suelo/metabolismoRESUMEN
Langerhans cell histiocytosis (LCH) is a proliferative disorder of dendritic cells which has evaded efforts to clearly define pathogenesis, diagnostic criteria, and therapeutic response markers. Strides have been made at classification with the recent development of a quantified score of disease severity. Splenic involvement is an indicator of poor prognosis, with spleen size its surrogate marker in evaluation and scoring. We describe a case of pediatric LCH with progressive splenomegaly despite treatment, which when examined at splenectomy revealed no LCH involvement but extramedullary hematopoiesis. These findings thus challenge our understanding of splenomegaly as a marker of disease.
Asunto(s)
Hematopoyesis Extramedular , Histiocitosis de Células de Langerhans/complicaciones , Histiocitosis de Células de Langerhans/tratamiento farmacológico , Esplenomegalia/etiología , Antineoplásicos/uso terapéutico , Histiocitosis de Células de Langerhans/fisiopatología , Humanos , Lactante , Recién Nacido , Masculino , Terapia Recuperativa , Esplenectomía , Esplenomegalia/cirugíaRESUMEN
The University Hospital of North Norway selected a web-based ulcer record used in Denmark, available from mobile phones. Data was stored in a common database and easily accessible. According to Norwegian legislation, only employees of the organization that owns an IT system can access the system, and use of mobile units requires strong security solutions. The system had to be changed. The paper addresses interactions in order to make the system legal, and assesses regulations that followed. By addressing conflicting scripts and the contingent nature of knowledge, we conducted a formative evaluation aiming at improving the object being studied. Participatory observation in a one year process, minutes from meetings and information from participants, constitute the data material. In the technological domain, one database was replaced by four. In the health care delivery domain, easy access was replaced by a more complicated log on procedure, and in the domain of law and security, a clarification of risk levels was obtained, thereby allowing for access by mobile phones with today's authentication mechanisms. Flexibility concerning predefined scripts was important in all domains. Changes were made that improved the platform for further development of legitimate communication of patient data via mobile units. The study also shows the value of formative evaluations in innovations.
Asunto(s)
Informática Médica/legislación & jurisprudencia , Informática Médica/métodos , Úlcera/diagnóstico , Acceso a la Información , Seguridad Computacional , Computadoras de Mano , Conducta Cooperativa , Bases de Datos Factuales , Dinamarca , Sistemas de Información en Hospital , Humanos , Internet , Noruega , Sistema de Registros , Programas Informáticos , Úlcera/epidemiologíaRESUMEN
OBJECTIVES: We hypothesized that older patients in a regional ST-elevation myocardial infarction (STEMI) transfer program would attain comparable treatment to younger patients. BACKGROUND: Older patients have been either excluded or underrepresented in STEMI clinical trials. Observational studies suggest that these patients are less likely to receive adjunctive pharmacologies and reperfusion therapy-thrombolysis or percutaneous coronary intervention (PCI)-and therapy is frequently delayed. METHODS: We identified a consecutive series of 2,262 STEMI patients (March 2003-December 2008) who either presented or were transferred to Abbott Northwestern Hospital for PCI (<65 years [n = 1285], 65-74 years [n = 436], 75-84 years [n = 381], and ≥85 years [n = 160]). Main outcome measures included time-to-reperfusion therapy, adjunctive medications received, and all-cause mortality. RESULTS: Overall time-to-reperfusion therapy was similar across age strata-94 minutes (<65 years), 101 minutes (65-74 years), 106 minutes (75-84 years), and 103 minutes (≥85 years). No difference in adjunctive antiplatelet or anticoagulant medications was seen at hospital admission, and only slight differences in standard post-myocardial infarction medication use were seen by age at hospital discharge. Age was an independent predictor of in-hospital and yearly mortality up to 5 years (1-year mortality 3.4% [<65 years], 9.2% [65-74 years], 15.2% [75-84 years], and 28.9% [≥85 years]; P < .0001). CONCLUSIONS: Older patients receive similar care to younger patients when treated in a regional STEMI transfer program. Although all-cause mortality in the elderly is increased, the absolute rates are lower than previously established. Our data suggest primary PCI (including transfer) can be applied to all appropriate STEMI patients, regardless of age.
Asunto(s)
Angioplastia Coronaria con Balón , Infarto del Miocardio/mortalidad , Infarto del Miocardio/terapia , Factores de Edad , Anciano , Anciano de 80 o más Años , Femenino , Mortalidad Hospitalaria , Humanos , Masculino , Factores de Tiempo , Resultado del TratamientoRESUMEN
BACKGROUND: The Internet is a growing and important source of a multitude of health-related services, the majority of which are information services. New kinds of services are, however, being established, on which the users are patients and the providers are health care professionals. MATERIAL AND METHODS: Health-related websites are considered from a legal point of view, especially in relation to the legal term of "health care" and the requirements in Norwegian legislation concerning adequate services from the health care professions. RESULTS: Health-related websites need to be categorised for the purpose of considerations of when to apply the health care legislation and how the requirements in this legislation can be applied in practice. INTERPRETATION: We shall soon see that the increasing demand for and use of various health-related websites on the Internet will lead to more services being offered. This is an interesting trend, but quality assurance will require that it be clarified what status they have under the legislation.